Parkinsons Disease

Papers
(The TQCC of Parkinsons Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function18
The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson’s Disease17
Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage17
Effect of NTN and Lmx1α on the Notch Signaling Pathway during the Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Dopaminergic Neuron-Like Cells15
α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson’s Disease12
Treatment Satisfaction and Its Influencing Factors in Parkinson’s Disease: A Web-Based Survey of Patients and Physicians in Clinical Practice in Japan12
Reverse Visually Guided Reaching in Patients with Parkinson’s Disease9
Association between Baseline Cognitive Score and Postoperative Delirium in Parkinson’s Disease Patients following Deep Brain Stimulation Surgery7
The Rehabilitative Effect of Archery Exercise Intervention in Patients with Parkinson’s Disease7
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease7
Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson’s Dise6
Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features6
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease6
Exploring the Caregiver Role after Deep Brain Stimulation Surgery for Parkinson’s Disease: A Qualitative Analysis6
Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson’s Disease: A Randomized Controlled Trial5
Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control Study5
Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort5
An Investigation into the Use and Meaning of Parkinson’s Disease Clinical Scale Scores5
Impact of Progression of Parkinson’s Disease on Swallowing Ability and Oral Environment5
The Current State of Parkinsonism in West Africa: A Systematic Review5
Validity and Reliability of the Persian Version of Parkinson’s Disease Sleep Scale-25
Effectiveness and Feasibility of Nonpharmacological Interventions for People With Parkinson’s Disease and Cognitive Impairment on Patient‐Centred Outcomes5
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods5
Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review5
5
Prevalence of Fabry Disease among Patients with Parkinson’s Disease4
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality4
Evaluation of Motor Complications in Parkinson’s Disease: Understanding the Perception Gap between Patients and Physicians4
Validation of the Non-Motor Symptoms Scale for Parkinson’s Disease of Persian Version4
Movement Disorders Associated with COVID-194
Central Pain in Parkinson’s Disease: Behavioral and Cognitive Characteristics4
Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson’s Disease4
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors4
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models4
The Lived Experience of Caregiving and Perception of Service Provision among Family-Caregivers of People with Late-Stage Parkinson’s: A Qualitative Study4
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis4
Single-Cell Analyses Reveal Necroptosis’s Potential Role in Neuron Degeneration and Show Enhanced Neuron-Immune Cell Interaction in Parkinson’s Disease Progression3
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review3
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression3
Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis3
Intestinal Transit in Early Moderate Parkinson’s Disease Correlates with Probable RBD: Subclinical Esophageal Dysmotility Does Not Correlate3
How Cognitive Reserve should Influence Rehabilitation Choices using Virtual Reality in Parkinson’s Disease3
Evaluation of Patients with Parkinson’s Disease in Intensive Care Units: A Cohort Study3
The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson’s Disease Model: A Dual-Tracer PET Study3
Validation of the Parkinson’s Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy3
Implications of Convolutional Neural Network for Brain MRI Image Classification to Identify Alzheimer’s Disease3
Two-Channel Portable Biopotential Recording System Can Detect REM Sleep Behavioral Disorder: Validation Study with a Comparison of Polysomnography3
Clozapine for Quetiapine‐Refractory Psychosis in Parkinson’s Disease: A Long‐Term Single‐Center Retrospective Study3
Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism3
0.049240112304688